Treatment of Opioid Use Disorder Course - APU - Saturday, February 10, 2024

4.67 (3 votes)

  • Registration Closed

Treatment of Opioid Use Disorder Course 

DEA Required SUD education certified seal

Host: Azusa Pacific University
Saturday, February 10, 2024| 9:00 am - 1:30 pm PT
Blended Course

Overview

This 8-hour, blended course (4 hours on-demand, 4 hours live-virtual) provides required education to qualify to prescribe buprenorphine in an office-based setting and covers essential information for providers to identify, assess, diagnose, and manage patients with opioid use disorder (OUD).  

This blended course combines 4 hours of online learning followed by 4 hours of live-virtual learning. The live-virtual portion of the course builds off content delivered in the online portion. Course faculty are expecting learners to complete the online portion before attending the live portion. You must complete both portions to receive credit for the course. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training.

The target audience for this introductory activity includes: 

  • Physicians who wish to obtain a waiver to prescribe buprenorphine in office-based treatment of opioid use disorders.
  • Clinicians and healthcare team members working with providers who prescribe buprenorphine in office-based treatment of opioid use disorders.

This activity addresses the following ACGME Competencies: Patient Care and Medical Knowledge.

Please Note: That recent legislation has removed the waiver requirement to prescribe buprenorphine. Some of the course content and descriptions refer to the waiver and we appreciate your patience as we work to update this content. To learn more about federal buprenorphine prescribing regulations, check out Policies Governing Buprenorphine for Opioid Use Disorder.

Learning Objectives

Upon completion, learners will be able to:

  1. Identify, assess and diagnose patients with opioid use disorder while considering severity, chronicity, individual characteristics, and psychiatric and medical comorbidities
  2. Develop an individualized, patient-centered treatment plan including negotiating treatment goals by evaluating appropriate medication- and psychosocial-based treatment options
  3. Monitor progress and modify treatment plan based on patient needs and progress toward treatment goals
  4. Implement best practices for office systems including team-based care to support treatment with medications for opioid use disorder
  5. Examine misconceptions, stigma, and complexities (bioethical, social, clinical, public health) associated with opioid use disorder and the use of medications to treat opioid use disorder


Registration Rates

ASAM Learner TypeRate
ASAM Member$0
Non-Member$0
Associate Member$0
Resident Member*$0
Student Member*$0

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Cancellations

Please reach out to Education@ASAM.org for cancellation. 

Registration Deadline: 02/10/2024

Close Access Date: 03/10/2027

Course Instructions

  1. Click on the Contents tab to begin the on-demand modules.
  2. Click on the Contents tab to attend the virtual-live session.
  3. Click Complete Evaluation to provide valuable activity feedback from the live portion of the course. Scroll down on all questions as there may be answer options that expand past the size of the window. 
  4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Matthew Torrington

MD, DFASAM

Dr. Torrington is a board certified by the American Academy of Family Medicine and the American Board of Addiction Medicine. He is a distinguished fellow of the American Society of Addiction Medicine, a member of the Committee on Treatment of Opioid Dependence of the California Society of Addiction Medicine, and is a certified Medical Review Officer. Dr. Torrington maintains a private practice focusing on the longitudinal disease management of addiction and pain. Dr. Torrington’s clinical focus is the treatment of stimulant use disorders, alcohol use disorders, opiate use disorders, and pain. As a participant in the development and implementation of significant research studies, he has served as Principal Investigator, co-investigator, and study physician for numerous clinical trials. For over fifteen years, Dr Torrington has been involved in the clinical use, clinical research, and education of physicians regarding various formulations of buprenorphine. In 2007, Dr. Torrington started a treatment venue in association with Common Ground Westside in Santa Monica, CA providing no-cost, low-barrier care to people with addiction issues. Since 2016 when the venue was subsumed by the Venice Family Clinic, where Dr. Torrington has continued to support the effort, and provide care pro bono to those in need, while also delivering clinical instruction to numerous providers new to Addiction Medicine. Dr. Torrington has contributed to many inpatient, outpatient and residential treatment centers providing a wide range of treatment to those in need. Dr. Torrington’s private practice is focused on helping those suffering with addiction and pain develop and implement comprehensive individualized multimodal treatment plans that address the biologic, psychological, social, spiritual and nutritional factors in their lives.

No relevant financial disclosures

Accreditation & Credit Designation Statements

Joint Accreditation Statement
image

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

The American Society of Addiction Medicine designates this enduring material for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

This activity awards 8 Nursing contact hours.

Pharmacy

This activity will offer 4 pharmacy contact hours (4 CEUs). Pharmacists will be asked to provide identifying information (e-Profile ID and DOB in MMDD format) in order to receive credit and allow reporting to CPE Monitor. (UAN: JA0000141-0000-24-001-H99-P)

PAs
image

ASAM has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8 AAPA Category 1 CME credits. Approval is valid until 11/12/2026. PAs should only claim credit commensurate with the extent of their participation.

Social Workers

As a Jointly Accredited Organization, ASAM is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 8 general continuing education credits.

IPCE Credit

This activity was planned by and for the healthcare team, and learners will receive 4 Interprofessional Continuing Education (IPCE) credits for learning and change.

National Board for Certified Counselors ACEP

The American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. The American Society of Addiction Medicine is solely responsible for all aspects of the programs.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1225.

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1224.

Continuing Education Credits (CEUs)

Upon completion of the activity and online evaluation, all other participants may request a certificate of participation. Participants may submit this certificate of participation to their professional organization/institute as documentation for completing this accredited continuing activity.

Maintenance of Certification (MOC) or Continuing Certification Programs (CCP)

This activity meets the requirements for MOC/CCP for the following primary physician boards and for state licensing CME requirements. MOC Credit is only reported for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.

  • American Board of Medical Specialties (ABMS)
  • American Board of Preventive Medicine (ABPM)
  • American Board of Internal Medicine (ABIM)
  • American Board of Pediatrics (ABP)
  • American Board of Surgery (ABS)
  • American Board of Psychiatry and Neurology (ABPN)
  • American Board of Addiction Medicine (ABAM)
  • Royal College of Physicians and Surgeons of Canada (RCPSC)
    • Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons in Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Information

In accordance with disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. These policies include mitigating all relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee members and Presenters have disclosed all financial relationship information. The ASAM CE Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

Key:

Complete
Failed
Available
Locked
Complete Pre-Course Survey
2 Questions
2 Questions This survey has 2 questions.
Complete Course Overview
Begin self-paced component package.
Begin self-paced component package. This activity will take 1 hour to complete. This activity was last reviewed and updated in December 2023.
Complete Module 1 - Identifying, Assessing, and Diagnosing Patients with Opioid Use Disorder
Begin self-paced component package.
Begin self-paced component package. This activity will take 1 hour to complete. This activity was last reviewed and updated in December 2023.
Complete Post Test - Module 1
5 Questions  |  10 attempts  |  4/5 points to pass
5 Questions  |  10 attempts  |  4/5 points to pass This post-test has 5 questions and requires 4 out of 5 questions to pass the test.
Complete Module 2 - Determining Treatment Plan for Patients with Opioid Use Disorder
Begin self-paced component package.
Begin self-paced component package. This activity will take 1 hour to complete. This activity was last reviewed and updated in December 2023.
Complete Post Test - Module 2
5 Questions  |  10 attempts  |  4/5 points to pass
5 Questions  |  10 attempts  |  4/5 points to pass This post-test has 5 questions and requires 4 out of 5 questions to pass the test.
Complete Module 3: Implementing Office Based Opioid Treatment
Begin self-paced component package.
Begin self-paced component package. This activity will take 1 hour to complete. This activity was last reviewed and updated in December 2023.
Complete Post Test - Module 3
5 Questions  |  10 attempts  |  4/5 points to pass
5 Questions  |  10 attempts  |  4/5 points to pass This post-test has 5 questions and requires 4 out of 5 questions to pass the test.
Attend Live Virtual Course - February 10, 2024
02/10/2024 at 12:00 PM (EST)  |  270 minutes
02/10/2024 at 12:00 PM (EST)  |  270 minutes https://apu.zoom.us/j/89788468719
Complete Post Test - Module 4
5 Questions  |  10 attempts  |  4/5 points to pass
5 Questions  |  10 attempts  |  4/5 points to pass This post-test has 5 questions and requires 4 out of 5 questions to pass the test.
Complete Post Test - Module 5
4 Questions  |  10 attempts  |  3/4 points to pass
4 Questions  |  10 attempts  |  3/4 points to pass This post-test has 4 questions and requires 3 out of 4 questions to pass the test.
Complete Evaluation
14 Questions
Complete Presenter Evaluation
3 Questions
Claim Credit & Certificate
Up to 8.00 medical credits available  |  Certificate available
Up to 8.00 medical credits available  |  Certificate available Participants should claim only the credits commensurate with the extent of their participation in the activity.